Close

Tag: Coronavirus information (COVID-19)

Aspen Pharmacare, Johnson & Johnson announce deal to produce COVID-19 vaccine candidate

South African pharmaceutical company Aspen Pharmacare on Tuesday announced its deal with the American firm Johnson & Johnson to jointly manufacture its COVID-19 vaccine...

CureVac COVID-19 vaccine induces immune response in early trial

German vaccine maker CureVac on Monday said that interim results from early trials showed that its investigational Covid-19 vaccine candidate, CvnCoV, appeared safe and...

Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution

Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from clinical through commercialization,  announced...

Novartis, Molecular Partners team up to develop DARPin therapeutics for COVID-19

Novartis and Molecular Partners AG announced a collaboration in the form of an option and license agreement to develop, manufacture and commercialize Molecular Partners’...

Lonza Announces Agreement to Manufacture AstraZeneca’s COVID-19 Long-Acting Antibody Combination

Lonza announced that the company has signed an agreement with AstraZeneca to manufacture AZD7442, a combination of two long-acting antibodies (LAABs) for the potential...

Novavax Provides Phase 3 COVID-19 Vaccine Clinical Development Update

Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced updates on its Phase 3 clinical development program of NVX-CoV2373,...

Boehringer Ingelheim Begins Phase 2 Clinical Trial of a Targeted Therapy to Help People with Severe Respiratory Illness from COVID-19

Boehringer Ingelheim announced the initiation of a Phase 2 clinical trial of BI 764198, an inhibitor of TRPC6, a receptor-operated cation channel. This potent...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read